Regulation of brain iron and copper homeostasis by brain barrier systems: Implication in neurodegenerative diseases

Abstract

Iron (Fe) and copper (Cu) are essential to neuronal function; excess or deficiency of either is known to underlie the pathoetiology of several commonly known neurodegenerative disorders. This delicate balance of Fe and Cu in the central milieu is maintained by the brain barrier systems, i.e., the blood-brain barrier (BBB) between the blood and brain interstitial fluid and the blood- cerebrospinal fluid barrier (BCB) between the blood and cerebrospinal fluid (CSF). This review provides a concise description on the structural and functional characteristics of the brain barrier systems. Current understanding of Fe and Cu transport across the brain barriers is thoroughly examined, with major focuses on whether the BBB and BCB coordinate the direction of Fe and Cu fluxes between the blood and brain/CSF. In particular, the mechanism by which pertinent metal transporters in the barriers, such as the transferrin receptor (TfR), divalent metal transporter (DMT1), copper transporter (CTR1), ATP7A/B, and ferroportin (FPN), regulate metal movement across the barriers is explored. Finally, the detrimental consequences of dysfunctional metal transport by brain barriers, as a result of endogenous disorders or exogenous insults, are discussed. Understanding the regulation of Fe and Cu homeostasis in the central nervous system aids in the design of new drugs targeted on the regulatory proteins at the brain barriers for the treatment of metal’s deficiency or overload-related neurological diseases.

Methanobactin reverses acute liver failure in a rat model of Wilson disease

“…Hepatic copper transport and homeostasis require various membrane transporters, a subset of intracellular copper chaperones (43), and low-molecular-weight binding partners like glutathione (44), but also as-yet uncharacterized intracellular ligands (4,45). Copper enters the cell via high-affinity transporters like copper transporter 1, and it is believed that differential copper affinities of the binding partners direct the metal to its final cellular destination (44).…”

Characterization of cellular uptake and toxicity of aminosilane-coated iron oxide nanoparticles with different charges in central nervous system-relevant cell culture models

“…High levels of iron have been found in autopsy section from patients with neurodegenerative disease, for example, Alzheimer's disease, Huntington's disease, and Parkinson's disease, 5,6 leading to the suggestion that elevated iron concentrations within the brain contribute to the development of neurodegenerative disease. However, it is not clear whether the imbalanced iron homeostasis in the brain is the cause of the disease state or the consequence of the disease process.…”

Superficial siderosis associated with aceruloplasminemia. Case report

“…Excess iron in the CSF, if present, is normally transported into the blood stream via the blood-CSF barrier and into the brain parenchyma via the CSF-brain barrier by mechanisms that have not defined precisely [15]. In some pathological conditions developing SS, macrophages may be loaded with excessive amounts of iron.…”